Public Company

Genflow Biosciences PLC

Driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.

About

Glenflow is a UK based biotech company dedicated to the development and commercialization of novel therapeutics targeting aging in dogs and humans. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has shown promising preclinical results.

Overview

Founded 2020
Type Public
Longevity related Yes
Location United Kingdom, UK

Stock

GENF

Join the Insiders Club.

Plain English. Every week. Free.